MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 219 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $59,493,000 | +10.1% | 1,133,627 | -30.2% | 0.02% | 0.0% |
| Q2 2020 | $54,027,000 | -8.8% | 1,623,901 | -25.5% | 0.02% | -23.8% |
| Q1 2020 | $59,271,000 | +35.8% | 2,179,071 | -1.5% | 0.02% | +75.0% |
| Q4 2019 | $43,646,000 | +55.8% | 2,212,165 | +2.3% | 0.01% | +33.3% |
| Q3 2019 | $28,022,000 | +8.4% | 2,162,165 | +4.1% | 0.01% | +12.5% |
| Q2 2019 | $25,861,000 | -4.0% | 2,077,204 | +12.1% | 0.01% | -11.1% |
| Q1 2019 | $26,931,000 | +36.9% | 1,853,469 | +4.0% | 0.01% | +28.6% |
| Q4 2018 | $19,673,000 | -29.7% | 1,781,990 | +67.6% | 0.01% | -22.2% |
| Q3 2018 | $27,965,000 | +41.9% | 1,063,318 | +10.3% | 0.01% | +28.6% |
| Q2 2018 | $19,714,000 | +30.1% | 964,024 | +15.5% | 0.01% | +40.0% |
| Q1 2018 | $15,150,000 | -48.7% | 834,716 | -60.6% | 0.01% | -54.5% |
| Q4 2017 | $29,559,000 | -19.7% | 2,118,884 | +6.5% | 0.01% | -21.4% |
| Q3 2017 | $36,799,000 | +13.4% | 1,989,109 | +3.6% | 0.01% | +7.7% |
| Q2 2017 | $32,440,000 | +54.2% | 1,919,551 | +21.8% | 0.01% | +44.4% |
| Q1 2017 | $21,039,000 | -7.1% | 1,575,964 | +4.7% | 0.01% | -10.0% |
| Q4 2016 | $22,650,000 | +34.8% | 1,504,994 | 0.0% | 0.01% | +25.0% |
| Q3 2016 | $16,804,000 | +10.7% | 1,504,994 | +7.1% | 0.01% | +14.3% |
| Q2 2016 | $15,174,000 | +42.1% | 1,404,994 | +21.6% | 0.01% | +40.0% |
| Q1 2016 | $10,680,000 | -37.7% | 1,155,882 | 0.0% | 0.01% | -44.4% |
| Q4 2015 | $17,153,000 | -9.6% | 1,155,882 | 0.0% | 0.01% | -10.0% |
| Q3 2015 | $18,968,000 | -28.1% | 1,155,882 | 0.0% | 0.01% | -23.1% |
| Q2 2015 | $26,366,000 | +64.3% | 1,155,882 | +9.5% | 0.01% | +62.5% |
| Q1 2015 | $16,049,000 | +26.2% | 1,055,882 | 0.0% | 0.01% | +33.3% |
| Q4 2014 | $12,713,000 | +120.6% | 1,055,882 | +107.8% | 0.01% | +100.0% |
| Q3 2014 | $5,763,000 | -42.9% | 508,201 | -39.2% | 0.00% | 0.0% |
| Q2 2014 | $10,098,000 | +107.4% | 835,896 | +100.0% | 0.00% | 0.0% |
| Q1 2014 | $4,869,000 | -34.1% | 417,948 | 0.0% | 0.00% | -25.0% |
| Q4 2013 | $7,389,000 | +22.9% | 417,948 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $6,014,000 | +14.4% | 417,948 | +19.7% | 0.00% | +33.3% |
| Q2 2013 | $5,256,000 | +41.4% | 349,030 | +25.3% | 0.00% | +50.0% |
| Q1 2013 | $3,716,000 | -8.5% | 278,607 | 0.0% | 0.00% | -33.3% |
| Q3 2012 | $4,059,000 | +2.4% | 278,607 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $3,962,000 | – | 278,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MONROE HALL ASSET MANAGEMENT LLC | 200,000 | $3,282,000 | 1.60% |
| SECTOR GAMMA AS | 350,920 | $5,759,000 | 1.56% |
| Opaleye Management Inc. | 160,000 | $2,626,000 | 1.29% |
| Visium Asset Management, LP | 5,398,088 | $88,583,000 | 1.21% |
| Palo Alto Investors LP | 1,455,176 | $23,879,000 | 1.15% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 4,597,915 | $75,452,000 | 0.84% |
| Sivik Global Healthcare LLC | 90,000 | $1,477,000 | 0.72% |
| Campbell & CO Investment Adviser LLC | 45,887 | $753,000 | 0.50% |
| Apex Capital Management | 1,096,757 | $17,998,000 | 0.41% |
| AlphaMark Advisors, LLC | 42,651 | $700,000 | 0.39% |